Camelot Portfolios, LLC Bristol Myers Squibb CO Transaction History
Camelot Portfolios, LLC
- $179 Million
- Q2 2024
A detailed history of Camelot Portfolios, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Camelot Portfolios, LLC holds 560 shares of BMY stock, worth $27,854. This represents 0.01% of its overall portfolio holdings.
Number of Shares
560Holding current value
$27,854% of portfolio
0.01%Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,400Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.28 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.89 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.55 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.71 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.94 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $106B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...